Apolipoprotein C-II anticorps (AA 31-101) (FITC)

N° du produit ABIN1709070

Détail du produit anti-Apolipoprotein C-II anticorps (FITC)

Antigène: Apolipoprotein C-II (APOC2)

Épitope: AA 31-101

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Apolipoprotein C-II est conjugé à/à la FITC

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Humain, Souris

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human Apolipoprotein CII/APOC2

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur Apolipoprotein C-II

Antigène: Apolipoprotein C-II (APOC2)

Autre désignation: APOC2 (APOC2 Produits)

Synonymes: anticorps apoc2, anticorps apoC-II, anticorps fb98g08, anticorps wu:fb52e03, anticorps wu:fb71a04, anticorps wu:fb98g08, anticorps APOC2, anticorps APO-CII, anticorps APOC-II, anticorps RGD1560725, anticorps APOCII, anticorps Apo-CII, anticorps ApoC-II, anticorps apolipoprotein C-II, anticorps apolipoprotein C2, anticorps apoc2, anticorps APOC2, anticorps Apoc2

Sujet:

Synonyms: APC 2, APC2, Apo CII, APOC 2, ApoC II, apoC-II ,APOC2, APOC2 protein, ApoCII, Apolipoprotein C II, Apolipoprotein C II precursor, ApolipoproteinCII, MGC75082,

Background: Apolipoproteins are protein components of plasma lipoproteins (1). The apolipoprotein C gene family encodes four homologous proteins designated apoC-I to -IV, which specifically modulate the metabolism of triglyceride-rich lipoproteins (2). The human apoC-I gene maps to chromosome 19q13.2 and is expressed primarily in the liver where it is activated when monocytes differentiate into macrophages (3,4). The human apoC-II gene maps to chromosome 19q13.2 and encodes a 79 amino acid single chain protein that is a necessary cofactor for the activation of lipoprotein lipase, the enzyme that hydrolyzes triglycerides in plasma and transfers the fatty acids to tissues (57). The human apoC-III gene maps to chromosome 11q23 and encodes a protein that may delay catabolism of triglyceride-rich particles by inhibiting lipoprotein lipase and hepatic lipase (8). The human apoC-IV gene maps to chromosome 19q13.2 and encodes a 127 amino acid protein that is primarily expressed in the liver (9,10).

ID gène: 344

Pathways: Lipid Metabolism